Viatris (VTRS) Deferred Taxes (2019 - 2026)
Viatris (VTRS) posted Deferred Taxes of -$124.5 million for Q2 2026, down 78.62% on a QoQ basis from -$69.7 million in Q1 2026, and down 162.11% year-over-year from $200.5 million in Q2 2025.
Analysis
Viatris (VTRS) Deferred Taxes (2019 - 2026) Analysis & Trends
Viatris has reported Deferred Taxes for 8 years, with the latest figure at -$124.5 million in Q2 2026.
- On a quarterly basis, Deferred Taxes fell 162.11% year-over-year to -$124.5 million in Q2 2026; TTM through Jun 2026 was -$579.6 million, a 11.16% increase from a year earlier, with the FY2025 full-year figure at -$476.5 million, up 37.92% from the prior year.
- Deferred Taxes was -$124.5 million for Q2 2026 at Viatris, down from -$69.7 million in the prior quarter.
- The five-year high for Deferred Taxes was $153.6 million in Q4 2022, with the low at -$312.4 million in Q3 2024.
- Average Deferred Taxes over 5 years is -$102.8 million, with a median of -$77.4 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Deferred Taxes surged 390.36% in 2022, then plunged 288.13% in 2023.
- Over 5 years, Deferred Taxes stood at $153.6 million in 2022, then tumbled by 234.9% to -$207.2 million in 2023, then retreated by 20.13% to -$248.9 million in 2024, then rose by 0.28% to -$248.2 million in 2025, then jumped by 49.84% to -$124.5 million in 2026.
- The last three Deferred Taxes figures came in at -$124.5 million (Q2 2026), -$69.7 million (Q1 2026), and -$248.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 25.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -124.50 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 12.44 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 17.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 59,000.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -4.94 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -124.50 Mn |
| Mar 31, 2026 | -69.70 Mn |
| Dec 31, 2025 | -248.20 Mn |
| Sep 30, 2025 | -137.20 Mn |
| Jun 30, 2025 | -47.50 Mn |
| Mar 31, 2025 | -43.60 Mn |
| Dec 31, 2024 | -248.90 Mn |
| Sep 30, 2024 | -312.40 Mn |
| Jun 30, 2024 | -154.40 Mn |
| Mar 31, 2024 | -51.90 Mn |
| Dec 31, 2023 | -207.20 Mn |
| Sep 30, 2023 | -85.00 Mn |
| Jun 30, 2023 | -68.20 Mn |
| Mar 31, 2023 | -26.70 Mn |
| Dec 31, 2022 | 153.60 Mn |
| Sep 30, 2022 | -21.90 Mn |
| Jun 30, 2022 | -104.80 Mn |
| Mar 31, 2022 | -52.80 Mn |
| Dec 31, 2021 | -52.90 Mn |
| Sep 30, 2021 | 147.00 Mn |